Published in Int Semin Surg Oncol on April 08, 2005
Breast imaging: A survey. World J Clin Oncol (2011) 0.83
The potential role of dynamic thermal analysis in breast cancer detection. Int Semin Surg Oncol (2006) 0.75
Reference breast temperature: proposal of an equation. Einstein (Sao Paulo) (2015) 0.75
Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med (1998) 12.20
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med (2004) 8.91
Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (1989) 7.30
Screening for breast cancer. JAMA (2005) 4.56
Evaluation of a palpable breast mass. N Engl J Med (1992) 3.85
Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology (2005) 2.65
A review of electrical impedance techniques for breast cancer detection. Med Eng Phys (2003) 1.56
Thermopathology of breast cancer: measurement and analysis of in vivo temperature and blood flow. Ann N Y Acad Sci (1980) 1.23
Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat (2005) 1.20
Mammary ductoscopy: current status and future prospects. Eur J Surg Oncol (2005) 1.16
Increased temperature of malignant urinary bladder tumors in vivo: the application of a new method based on a catheter technique. J Clin Oncol (2001) 0.96
Technology review: the use of electrical impedance scanning in the detection of breast cancer. Breast Cancer Res (2003) 0.93
Bimodal age-frequency distribution of epitheliosis in cancer mastectomies: relevance to preneoplasia. Cancer (1982) 0.92
Circadian rhythm chaos: a new breast cancer marker. Int J Fertil Womens Med (2001) 0.89
Evaluation of the ability of digital infrared imaging to detect vascular changes in experimental animal tumours. Int J Cancer (2004) 0.88
Mitotic circadian rhythm in a fast-growing and a slow-growing hepatoma: mitotic rhythm in hepatomas. J Natl Cancer Inst (1970) 0.88
Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging. Semin Nucl Med (1999) 0.87
Temperature differences are associated with malignancy on lung lesions: a clinical study. BMC Cancer (2003) 0.86
Risk factors for benign breast disease and their relation with breast cancer risk. Pooled information from epidemiologic studies. Tumori (1985) 0.86
Breast thermography is a noninvasive prognostic procedure that predicts tumor growth rate in breast cancer patients. Ann N Y Acad Sci (1993) 0.84
Thermovascular changes associated with in situ and minimal breast cancers. Results of an ongoing prospective study after four years. J Reprod Med (1987) 0.84
Prognosis and post-therapeutic follow-up of breast cancers by thermography. Bibl Radiol (1975) 0.83
Thermobiological assessment of benign and malignant breast diseases. Am J Obstet Gynecol (1983) 0.82
Mitotic rhythms in human cancer, reevaluated by electronic computer programs. Evidence for chronopathology. J Natl Cancer Inst (1966) 0.81
Thermal heterogeneity constitutes a marker for the detection of malignant gastric lesions in vivo. J Clin Gastroenterol (2003) 0.81
Twenty-four-hour variations in DNA synthesis of a fast-growing and a slow-growing hepatoma: DNA synthesis rhythm in hepatoma. J Natl Cancer Inst (1971) 0.80
The diagnosis of breast pre-cancer by the chronobra--I. Background review. Chronobiol Int (1989) 0.80
Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. Int Semin Surg Oncol (2005) 1.26
Oncological safety and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction. Surg Oncol (2008) 1.23
The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer (2009) 1.20
WNT5A expression in human breast cancer. Anticancer Res (2005) 1.18
hTERT mRNA expression correlates with telomerase activity in human breast cancer. Eur J Surg Oncol (2003) 1.13
hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression. Breast Cancer Res Treat (2003) 1.04
The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Anticancer Res (2007) 1.01
The prevention of breast cancer: an overview. Curr Med Res Opin (2001) 0.97
Management of gynaecomastia: an update. Int J Clin Pract (2007) 0.97
Evidence for a tumour suppressor function of SETD2 in human breast cancer: a new hypothesis. Anticancer Res (2010) 0.96
The significance of human telomerase reverse transcriptase (hTERT) in cancer. Eur J Surg Oncol (2001) 0.94
Breast papillomas: current management with a focus on a new diagnostic and therapeutic modality. Int Semin Surg Oncol (2006) 0.94
Mammographic breast density by area of residence: possible evidence of higher density in urban areas. Curr Med Res Opin (2008) 0.92
Evidence for the management of mastalgia. Curr Med Res Opin (2004) 0.90
In vitro fertilization and breast cancer risk: a review. Int J Fertil Womens Med (2006) 0.89
Control of aromatase activity in breast tumours: the role of the immune system. J Steroid Biochem Mol Biol (1997) 0.88
The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition. Eur J Surg Oncol (2002) 0.88
Screening mammography in women aged 40-49: is it time to change? Int Semin Surg Oncol (2006) 0.88
Does mammary ductoscopy have a role in clinical practice? Int Semin Surg Oncol (2006) 0.87
Does post-mastectomy radiotherapy represent a contraindication to skin-sparing mastectomy and immediate reconstruction: an update. Surg Oncol (2012) 0.87
Oncological considerations of skin-sparing mastectomy. Int Semin Surg Oncol (2006) 0.86
Evidence of a tumour suppressive function of E2F1 gene in human breast cancer. Anticancer Res (2008) 0.86
Insulin-like growth factor 1 (IGF-1) and its receptor mRNA levels in breast cancer and adjacent non-neoplastic tissue. Anticancer Res (2006) 0.85
Phytoestrogens and the risk of breast cancer: a review of the literature. Int J Fertil Womens Med (2006) 0.85
Core biopsy is accurate in determining the hormone receptor status of early breast cancer. Am J Surg (2004) 0.83
The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Breast Cancer Res Treat (2006) 0.83
Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer? Int Semin Surg Oncol (2005) 0.83
The evolving role of radiofrequency ablation therapy of breast lesions. Anticancer Res (2010) 0.83
Surgical excision for B3 breast lesions diagnosed by vacuum-assisted core biopsy. Anticancer Res (2010) 0.83
Abdominal ganglioneuromas in adults. Urol Int (2003) 0.82
Does c-erbB2/HER2 overexpression predict adjuvant tamoxifen failure in patients with early breast cancer? Eur J Surg Oncol (2001) 0.82
hTERT mRNA expression is associated with a poor clinical outcome in human breast cancer. Anticancer Res (2007) 0.82
The utility of MRI for the screening and staging of breast cancer. Int J Clin Pract (2008) 0.82
Pure antiestrogens and breast cancer. Curr Med Res Opin (2001) 0.82
Is MRI more accurate than CT in estimating the real size of adrenal tumours? Eur J Surg Oncol (2001) 0.82
Evidence of a tumour suppressor function for DLEC1 in human breast cancer. Anticancer Res (2010) 0.81
Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer. J Surg Oncol (2007) 0.81
Management of desmoid tumours including a case report of toremifene. Ann Oncol (1994) 0.81
Telomerase activity and Bcl-2 expression in human breast cancer. Eur J Surg Oncol (2002) 0.80
Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer. Oncol Rep (2013) 0.80
Evidence for a pro-apoptotic function of RACK1 in human breast cancer. Oncogene (2010) 0.80
Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer. Anticancer Res (2007) 0.80
Radial scars and breast cancer. N Engl J Med (1999) 0.79
The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer. Anticancer Res (2007) 0.79
Hot-water bottle induced thermal injury of the skin overlying Becker's mammary prosthesis. Breast (1999) 0.78
British women's choice between sentinel node biopsy and axillary node clearance for breast cancer. Curr Med Res Opin (2003) 0.78
HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR. Anticancer Res (2007) 0.78
Herceptin and breast cancer: an overview for surgeons. Surg Oncol (2008) 0.78
The evolving role of sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol (2003) 0.78
Dairy products and breast cancer risk: a review of the literature. Int J Fertil Womens Med (2006) 0.78
hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer. J Carcinog (2005) 0.78
Observations on the effects of Suppressor of Cytokine Signaling 7 (SOCS7) knockdown in breast cancer cells: their in vitro response to Insulin Like Growth Factor I (IGF-I). Clin Transl Oncol (2013) 0.77
The mRNA expression of DAP1 in human breast cancer: correlation with clinicopathological parameters. Cancer Genomics Proteomics (2012) 0.77
SYK expression in human breast cancer. J Carcinog (2005) 0.77
Magnetic resonance imaging for screening of women at high risk for hereditary breast cancer. J Clin Oncol (2001) 0.77
Evidence for a tumour suppressive function of APRG1 in breast cancer. Breast Cancer Res Treat (2005) 0.77
Exposure to traffic emissions throughout life and risk of breast cancer. Cancer Causes Control (2007) 0.77
Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer. Curr Med Res Opin (2003) 0.77
The accuracy of intraoperative frozen section analysis of the sentinel lymph nodes during breast cancer surgery. Int J Fertil Womens Med (2005) 0.76
Is dissection of the internerve tissue during axillary lymphadenectomy for breast cancer necessary? Eur J Surg Oncol (2000) 0.76
The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters. Anticancer Res (2012) 0.76
Breast cancer risk in flight attendants: an update. Int J Fertil Womens Med (2007) 0.76
Pneumothorax after a clinical breast fine-needle aspiration of a lump in a patient with Poland's syndrome. Int Semin Surg Oncol (2005) 0.76
Breast cancer chemoprevention: additional observations. Int J Clin Pract (2003) 0.75
Radiographic vs surgical size of renal tumours after partial nephrectomy. BJU Int (2000) 0.75
The mRNA expression of IGF-1 and IGF-1R in human breast cancer: association with clinico-pathological parameters. J Carcinog (2006) 0.75
Predictors of response to chemotherapy. J Clin Oncol (2000) 0.75
Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast. Br J Surg (1999) 0.75
Assessment of nipple discharge. J Surg Oncol (2000) 0.75
Telomerase activity in fine-needle aspirates of breast lesions. J Clin Oncol (1999) 0.75
Re: Mammography utilization among California women aged 40-49 in a managed care environment. Breast Cancer Res Treat (2002) 0.75
Adjuvant radiotherapy for DCIS. Lancet (2000) 0.75
Late results of skin-sparing mastectomy followed by immediate breast reconstruction (Br J Surg 2007; 94: 1220-1225). Br J Surg (2008) 0.75
Treatment of ductal carcinoma in situ. N Engl J Med (1999) 0.75
Nipple aspirate fluid in relation to breast cancer. Breast (2000) 0.75
Re: perioperative acute phase response modification by polyadenylic-polyuridylic acid. Eur J Surg Oncol (2000) 0.75
Continuous antibiotic treatment for experimental abdominal sepsis: effects on organ inflammatory cytokine expression and neutrophil sequestration. Br J Surg (1998) 0.75
Comment on prognostic and therapeutic implications of mTORC2 and rictor expression in human breast cancer. Breast Cancer Res Treat (2012) 0.75
Clinical significance of telomerase activity in the non-cancerous epithelial region of oesophageal squamous cell carcinoma. Br J Surg (1999) 0.75
Role of cytokines and growth factors in promoting the local recurrence of breast cancer. Br J Surg (1996) 0.75
The potential role of dynamic thermal analysis in breast cancer detection. Int Semin Surg Oncol (2006) 0.75
The role of urine cytology in the assessment of lower urinary tract symptoms. BJU Int (2000) 0.75
Sector resection for stage I breast cancer. J Clin Oncol (2000) 0.75
Benefits of post-mastectomy radiotherapy. Lancet (1998) 0.75
Surgical implications of underestimation of adrenal tumour size by computed tomography. Br J Surg (1999) 0.75
The effect of surgical wounding on tumour development. Eur J Surg Oncol (2000) 0.75
Grading of infiltrating lobular carcinoma. Eur J Surg Oncol (2001) 0.75
Breast weight and hormone receptor status in women with breast cancer. Int Semin Surg Oncol (2005) 0.75
Aromatase inhibitors. Curr Med Res Opin (2001) 0.75
Current concepts in cyclooxygenase inhibition in breast cancer. J Clin Pharm Ther (2002) 0.75
Infiltrating fibromatosis of the breast: a potential pitfall. Int J Clin Pract (2002) 0.75
Is there a link between breast cancer and abortion: a review of the literature. Int J Fertil Womens Med (2006) 0.75
Advances in breast oncology: the 2002 ASCO meeting. Curr Med Res Opin (2002) 0.75
General practitioners' greater choice for sentinel node biopsy than patients in the UK. Curr Med Res Opin (2004) 0.75